Editor,

*Toxoplasma gondii* is the causal agent of toxoplasmosis, a common parasitic infection of humans acquired either by ingestion of oocysts voided in cat faeces or tissue cysts in undercooked meat. In humans, infection is mainly asymptomatic or accompanied by mild self-limiting symptoms. Infection or reactivation in immunocompromised patients can have serious clinical consequences. Primary infection in pregnancy can lead to miscarriage, stillbirth or congenital toxoplasmosis. The majority of infected neonates do not have detectable disease at birth but carry a significant risk of developing ocular disease in later life. Historically, Northern Ireland has been considered and cited as the area with the highest toxoplasma seroprevalence in the UK at 40% in blood donors^[@cit0001]^, 36% in diagnostic samples^[@cit0002]^ and even higher seroprevalence rates in farmers in Northern Ireland of 73.5%^[@cit0003]^ However all this data actually relates to samples tested several decades ago. There has been no data in the literature on toxoplasma seroloprevalence in Northern Ireland population for more recent decades. The impression within our laboratory is that the seroprevalence rate has fallen dramatically and was now more in line with rest of UK. We set out to determine if this was the case.

Materials and Methods {#sec1}
=====================

A convenience set of 5787 samples received from January 2012 until September 2015 were tested routinely for *Toxoplasma gondii* IgG using either Vidas Toxoplasma IgG II assay (bioMérieux UK Ltd, Basingstoke, England) or Elecsys Toxo IgG (Roche Diagnostics, Rotkreuz, Switzerland)). Equivocal results were regarded as seronegative for purposes of analysis.

Results {#sec2}
=======

Of 5787 sera tested, 16.07% were seropositive but there was a marked reduction in seroprevalence with younger age ([table 1](#t0001){ref-type="table"} and [figure 1](#f0001){ref-type="fig"}). A total of 85% of samples from patients born between 1920 and 1929 were seropositive contrasting with 6% for patients born between 1990 and 1999.

###### 

Toxoplasma seroprevalence (IgG) data by age bands

  Year of birth   Positive/total tested (%positive)   Equivocal
  --------------- ----------------------------------- -----------
  1920-1929       17/20 (85.00)                       0
  1930-1939       48/84 (57.14)                       3
  1940-1949       135/358 (37.70)                     19
  1950-1959       165/583 (28.30)                     16
  1960-1969       130/724 (17.96)                     20
  1970-1979       169/1139 (14.83)                    10
  1980-1989       179/1555 (11.51)                    9
  1990-1999       50/795 (6.29)                       10
  2000-2015       37/529 (6.99)                       11
  TOTAL           930/5787 (16.07)                    98

![Toxoplasma seroprevalence by age band](umj0086-0043-f1){#f0001}

Discussion {#sec3}
==========

The most likely interpretation of this data is an age cohort effect suggesting that acquisition in childhood has decreased greatly over the past 50 years. It should be noted that the vast majority of the samples in the post-2010 DOB group were from babies and thus reflect maternal seroprevalence (similar to age cohorts 2 decades previously), hence explaining the slight apparent upward trend in this group.

Other countries such as France with previously reported high seroprevalence rates have seen marked decreases in seroprevalence^[@cit0004]^. It is likely that such decreases in toxoplasma seroprevalence are due to changes in animal husbandry and food exposure. Knowledge of current seroprevalence is important for understanding the epidemiology and determining approaches to congenital toxoplasmosis in Northern Ireland and similar countries.
